- Home
- VRPX vs EVOK Comparison
VRPX vs EVOK Comparison
Compare VRPX & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRPX
- EVOK
- Stock Information
- Founded
- VRPX 2016
- EVOK 2007
- Country
- VRPX United States
- EVOK United States
- Employees
- VRPX N/A
- EVOK N/A
- Industry
- VRPX Medicinal Chemicals and Botanical Products
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- VRPX Health Care
- EVOK Health Care
- Exchange
- VRPX Nasdaq
- EVOK Nasdaq
- Market Cap
- VRPX 3.7M
- EVOK 4.3M
- IPO Year
- VRPX 2021
- EVOK 2013
- Fundamental
- Price
- VRPX $0.62
- EVOK $4.58
- Analyst Decision
- VRPX Hold
- EVOK
- Analyst Count
- VRPX 1
- EVOK 0
- Target Price
- VRPX N/A
- EVOK N/A
- AVG Volume (30 Days)
- VRPX 108.5K
- EVOK 1.2M
- Earning Date
- VRPX 11-26-2024
- EVOK 11-07-2024
- Dividend Yield
- VRPX N/A
- EVOK N/A
- EPS Growth
- VRPX N/A
- EVOK N/A
- EPS
- VRPX N/A
- EVOK N/A
- Revenue
- VRPX N/A
- EVOK $8,617,036.00
- Revenue This Year
- VRPX N/A
- EVOK $124.10
- Revenue Next Year
- VRPX N/A
- EVOK $75.70
- P/E Ratio
- VRPX N/A
- EVOK N/A
- Revenue Growth
- VRPX N/A
- EVOK 100.35
- 52 Week Low
- VRPX $0.36
- EVOK $3.54
- 52 Week High
- VRPX $7.60
- EVOK $17.40
- Technical
- Relative Strength Index (RSI)
- VRPX 43.76
- EVOK 39.65
- Support Level
- VRPX $0.55
- EVOK $4.03
- Resistance Level
- VRPX $0.79
- EVOK $6.09
- Average True Range (ATR)
- VRPX 0.07
- EVOK 0.58
- MACD
- VRPX -0.01
- EVOK -0.20
- Stochastic Oscillator
- VRPX 27.96
- EVOK 20.52
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.